EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 271 (2021) E3S Web Conf., 271 (2021) 03042 References
Open Access
Issue
E3S Web Conf.
Volume 271, 2021
2021 2nd International Academic Conference on Energy Conservation, Environmental Protection and Energy Science (ICEPE 2021)
Article Number 03042
Number of page(s) 7
Section Research on Energy Chemistry and Chemical Simulation Performance
DOI https://doi.org/10.1051/e3sconf/202127103042
Published online 15 June 2021
  1. D.J. Newman and G.M. Cragg. Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010. Journal of natural products (2012): 75: 311. [CrossRef] [PubMed] [Google Scholar]
  2. D.J. Newman and G.M. Cragg. Natural Products as Sources of New Drugs from 1981 to 2014. Journal of Natural Products (2016): 629. [Google Scholar]
  3. G. MCragg, Grothaus P.G. and Newman D.J. Impact of natural products on developing new anti-cancer agents. J Chemical Reviews (2009): 109: 301243. [Google Scholar]
  4. W.J. Slichenmyer, E.K. Rowinsky, R.C. Donehower and S.H. Kaufmann. The Current Status of Camptothecin Analogues as Antitumor Agents. Journal of the National Cancer Institute: 271. [Google Scholar]
  5. S. Malik, R.M. Cusido, M.H. Mirjalili, E. Moyano, J. Palazonand M. Bonfill. Production of the anticancer drug taxol in Taxus baccata suspension cultures: A review. J Process Biochemistry (2011): 46: p.23–34. [CrossRef] [Google Scholar]
  6. AEO, AMEMS, AOK, ASS, AMC, AKE, et al. Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine International Journal of Phytotherapy Phytopharmacology (2015): 22: 1045–54. [CrossRef] [Google Scholar]
  7. Mukherjee, Ashis K., Basu, Sourav, Sarkar, Nabanita, et al. Advances in Cancer Therapy with Plant Based Natural Products. Current Medicinal Chemistry (2001). [Google Scholar]
  8. H. Maeda. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Advances in Enzyme Regulation (2001): 41: 189–207. [CrossRef] [PubMed] [Google Scholar]
  9. Y.C. Barenholz. Doxil — The first FDA-approved nano-drug: Lessons learned. Journal of Controlled Release (2012): 160: 117–34. [CrossRef] [Google Scholar]
  10. Jeffrey, Silverman, Steven and Deitcher. Marqibo? (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemotherapy & Pharmacology (2013). [Google Scholar]
  11. T.Y. Kim, D.W. Kim, J.Y. Chung, G.S. Sang and Bang Y.J. Kim, T.Y., Kim D.W., Chung, J.Y., Shin, S.G., Kim, S.C., Heo, D.S., Kim, N.K., Bang, Y.J. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res 10: 3708–3716. Clinical Cancer Research An Official Journal of the American Association for Cancer Research (2004 ): 10: 3708-16. [CrossRef] [PubMed] [Google Scholar]
  12. K.S. Lee, H.C. Chung, S.A. Im, Y.H. Park, C.S. Kim, S.B. Kim, et al. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Research & Treatment (2008): 108: 241–50. [CrossRef] [Google Scholar]
  13. M.R. Green, G.M. Manikhas, S. Orlov, B. Afanasyev, A.M. Makhson, Bhar P., et al. Abraxane((R)), a novel Cremophor((R))-free, albumin-bound particle form of paclitaxel for the treatment of advanced nonsmall-cell lung cancer. Annals of Oncology (2006): 17: 1263–68. [CrossRef] [Google Scholar]
  14. Torchilin and P. Vladimir. Recent advances with liposomes as pharmaceutical carriers. Nature Reviews Drug Discovery (2005). [Google Scholar]
  15. Saji, Uthaman, Kang Moo, Huh, In-Kyu, et al. Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications. Biomaterials research 2018. [Google Scholar]
  16. E.S. Lee, Z. Gao and H.B. You. Recent progress in tumor pH targeting nanotechnology. Journal of Controlled Release (2008): 132: 164–70. [CrossRef] [Google Scholar]
  17. Xiaohui, Pus, Luling, Zhao, Jia, Li, et al. A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin. Acta biomaterialia (2019). [Google Scholar]
  18. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer. Acs Applied Materials & Interfaces (2015): 7: 9691. [CrossRef] [PubMed] [Google Scholar]
  19. L. Zhu, T. Wang, F. Perche, A. Taigind and V.P. Torchilin. Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety. PNAS (2013): 110: 17047–52. [CrossRef] [Google Scholar]
  20. Cathcart J., Pulkoski-Gross A. and Cao J. Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas. Genes Dis (2015): 2: 26–34. [CrossRef] [PubMed] [Google Scholar]
  21. R. Cheng, F. Feng, F. Meng, C. Deng, J. Feijen and Z. Zhong. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. Journal of Controlled Release (2011): 152: 2–12. [CrossRef] [Google Scholar]
  22. AAR, BUH, CTR, DMB and EHMNI. "Smart" materials-based near-infrared light- responsive drug delivery systems for cancer treatment: A review - ScienceDirect. Journal of Materials Research Technology (2019): 8: 1497509. [Google Scholar]
  23. R. Ali, H. Uzma, R. Tahir, B. Muhammad and H. Iqbal M.N. Redox-responsive nano-carriers as tumor-targeted drug delivery systems. European Journal of Medicinal Chemistry (2018): 157: S0223523418307025-. [Google Scholar]
  24. Chunli, Shi, Xing, Guo, Qianqian, Qus, et al. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles. Biomaterials (2014). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.